In no-holds-barred action, the European Medicines Agency has accused India-based CRO GVK Biosciences of systematically faking clinical trials for about 700…

China biotech Innovent's recent success in raising $100 million in venture capital to help it build a pipeline of biosimilars could be a signal of how…

The private equity group announced this morning that it will buy out Medpace, continuing an M&A trend that has spurred a sizable shakeout of the CRO…

Avillion has scored one of its first risk-sharing deals on a late-stage pharma asset, striking a deal to do a Phase III study of Pfizer's Bosulif (…

In recent years, it has become dramatically easier and quicker to create a virtual drug-development company. Today it is even possible to take virtual to its…

In the pact, investigators at Merck Serono will join hands with experts at Quintiles to shape and guide the company's R&D strategy while the…

PRACS Institute, the CRO that attempted to rise Phoenix-like from the ashes of scandal-plagued Cetero, has reportedly slammed its doors shut, laying off…

For years now Big Pharma companies have been pouring billions into ambitious new research efforts in China, anxious to capitalize on one of the world's…

Outsourcing